SJSu Jiang

Su Jiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Su Jiang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Dissecting Cross-Border Bride Trafficking to China: A Crime Script Analysis Approach

    by Shuai Wei, Su Jiang, Fan Pan

    Bride trafficking is a complex and underexplored form of human trafficking. This article outlines the crime script of cross-border bride trafficking to China using content analysis of 607 Chinese court judgments. We identify six steps in the trafficking process, detailing the principal destinations of trafficked victims and mapping the geographic distribution of transit points. Special attention is given to both the vulnerabilities and the shifting agency of North Korean women, some of whom later become traffickers. We also highlight the strategic use of interpersonal relationships in sustaining and expanding trafficking operations. Finally, we propose targeted intervention strategies informed by situational crime prevention and crime script analysis, arguing for evidence-based, contextually grounded policy responses.


  • The Future of Deadly Synthetic Opioids: Nitazenes and Their International Control

    by Nicholas Lassi, Su Jiang

    Nitazenes, a class of highly potent illicit synthetic opioids, represent an escalating global public health threat due to their increasing consumption and rising occurrence of overdose mortality connected with their use. This study evaluates the dangers posed by nitazenes, details gaps in their current international and national regulatory and enforcement measures, and proposes solutions to diminish their impact. Focusing on China and India, the two states most linked with nitazene production, the United States, the primary consumer market, and the United Nations, this research details the challenges involved in controlling these substances. Central issues include the pace of the emergence of new analogs, regulatory inconsistencies across jurisdictions, and the limited capabilities in toxicological testing. Proposed strategies for improved control include compound‐wide bans, unifying national laws with international standards, and enhanced toxicology testing capabilities for emergency responders and forensic laboratories. These findings stress the need for an adaptive and coordinated response to meet the evolving nitazene threat, with implications for public health, addiction research, and international regulatory systems.


  • The Threat of Fentanyl‐Based Counterfeits in Mexican Pharmacies: Addressing a Growing Public Health Crisis

    by Nicholas Lassi, Su Jiang

    Pharmacists are perceived as protectors of public health, advancing trust in pharmacies and the drugs provided. However, this trust is often misplaced in Mexico, where pharmacists frequently dispense dangerous fentanyl‐based counterfeits without prescription orders and on‐demand. The convergence of four trends occurring in Mexico—the influx of international tourists seeking pharmaceuticals without prescription orders, increased domestic consumption of illicit fentanyl, expanded domestic production of illicit fentanyl, and the rise of fentanyl‐based counterfeits in Mexican pharmacies—has created a substantial risk to regional public health. Mexican cartels manufacture and distribute these counterfeit drugs, facilitated by corrupt officials engaged in limited drug enforcement. To address this emerging public health crisis, an independent fentanyl enforcement division should be established in Mexico to oversee expanded drug enforcement operations targeting cartels and their intermediaries. This division should conduct rigorous and surprise inspections of pharmacies accompanied by international observers and provide anonymous whistleblower channels for pharmacists and the public. Pharmacy owners found knowingly selling fentanyl‐based counterfeits should face severe penalties, including forfeiture of pharmacy licences, lifetime bans from owning and operating pharmacies, significant fines, and incarceration. By enacting these enforcement and public health reforms, Mexico can more effectively minimize the dispensation of fentanyl‐based counterfeits and safeguard regional public health.


  • Open Access

    The Legal and Ethical Dimensions of Hospital Visitation Bans in the COVID-19 Era

    by Nicholas Lassi, Su Jiang, Yu Du

    Background/Objectives: The COVID-19 pandemic compelled countries worldwide to implement stringent visitation restrictions across hospitals, nursing homes, and long-term care facilities to mitigate viral transmission. While initially justified by the uncertainty surrounding the virus, these restrictions often lasted well beyond the acute stage of the pandemic, leading to substantial psychological and physical harm, particularly for older adults. This study assesses the effects of these controls and offers strategies to balance public health priorities with patients’ rights and psychological well-being during public health crises. Methods: An integrative review and comparative analysis of legislative measures and the psychological effects of visitation restrictions was undertaken. International and national visitation regulations and case studies were reviewed, and ethical frameworks were considered. Results: Our findings indicate that prolonged isolation due to extended visitation restrictions led to higher rates of anxiety, depression, and delirium among patients, creating ethical dilemmas for healthcare providers. Legal responses to this challenge varied globally. International human rights organizations called for policies bridging public health priorities with patients’ rights to family and caregiver support. Some U.S. states enacted proactive legislation to strengthen family visitation rights, while other jurisdictions lack these visitation protections. Conclusions: Prolonged visitation restrictions during the pandemic show the need for legislation integrating public health protections with in-person family and caregiver support. The ethical imperatives of limiting the psychological harm caused by healthcare isolation and the legislative solutions to protect public health and the psychological well-being of patients during health crises are discussed.